PTGS1 and gastroesophageal reflux disease: We hypothesized that patients with GERD and/or a previous history of ulcer were susceptible to gastric complications by nature, but even without the nature of susceptibility, NSAIDs or antiplatelet drugs alone could penetrate the gastric mucous membrane by inhibiting cyclooxygenase-1 (COX-1).